Buchumschlag

Denosumab, for osteoporosis, reduces the incidence of type 2 diabetes, risk of foot ulceration and all‐cause mortality in adults, compared with bisphosphonates: An analysis of real‐world, cohort data, with a systematic review and meta‐analysis

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Alex E. Henney, David R. Riley, Ben O'Connor, Theresa J. Hydes, Matthew Anson, Sizheng Steven Zhao, Uazman Alam, Daniel J. Cuthbertson
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2024
Schlagworte:	Diabetes, Obesity and Metabolism
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Sodium–glucose cotransporter 2 inhibitors reduce the risk of incident type 2 diabetes in people with heart failure without diabetes: An analysis of real‐world, cohort data
von: Alex E. Henney, et al.
Veröffentlicht: (2024)

Metabolic bariatric surgery is associated with reduced adverse hepatic and extrahepatic outcomes, and lower all‐cause mortality, in patients with steatotic liver disease
von: Weronika Stupalkowska, et al.
Veröffentlicht: (2025)

Real‐world evaluation of teplizumab in type 1 diabetes: Progression to insulin requirement
von: Sahana Mahesh, et al.
Veröffentlicht: (2025)

The impact of insulin pump therapy compared to multiple daily injections on complications and mortality in type 1 diabetes: A real‐world retrospective cohort study
von: Sophie Haughton, et al.
Veröffentlicht: (2025)

Hydrogel dressings for diabetic foot ulcer: A systematic review and meta‐analysis
von: Hongjiao Zhao, et al.
Veröffentlicht: (2024)

Incretin‐based therapy and the risk of diabetic foot ulcers and related events
von: Nikki C. C. Werkman, et al.
Veröffentlicht: (2024)

Association of metabolic score for visceral fat with all‐cause mortality, cardiovascular mortality, and cancer mortality: A prospective cohort study
von: Shanshan Jia, et al.
Veröffentlicht: (2024)

Longitudinal exposure to non‐ HDL ‐C and cardiovascular events, all‐cause mortality in type 2 diabetes: A post hoc analysis of the ACCORD trial
von: Yueyue Wang, et al.
Veröffentlicht: (2026)

Continuous glucose monitoring and all‐cause mortality in insulin‐using population with diabetes and cognitive impairment
von: Pareeta Kotecha, et al.
Veröffentlicht: (2024)

Association of body roundness index with cardiovascular disease and all‐cause mortality among Chinese adults
von: Hong Lin, et al.
Veröffentlicht: (2025)

Risk factors for development of diabetic foot ulcer disease in two large contemporary UK cohorts
von: Safoora Gharibzadeh, et al.
Veröffentlicht: (2025)

Associations between Chinese visceral adiposity index and risks of all‐cause and cause‐specific mortality: A population‐based cohort study
von: Xiaoyan Wu, et al.
Veröffentlicht: (2024)

Graded association of muscle strength with all‐cause and cause‐specific mortality in older adults with diabetes: Prospective cohort study across 28 countries
von: Lars Louis Andersen, et al.
Veröffentlicht: (2024)

Impact of time in tight range on all‐cause and cardiovascular mortality in type 2 diabetes: A prospective cohort study
von: Jinghao Cai, et al.
Veröffentlicht: (2025)

Cardiovascular autonomic dysfunction precedes cardiovascular disease and all‐cause mortality: 11‐year follow‐up in the ADDITION ‐ PRO study
von: Jonas R. Schaarup, et al.
Veröffentlicht: (2025)

Sustained glucagon‐like peptide‐1 receptor agonist treatment improves glycemic control and reduces all‐cause mortality compared to dipeptidyl peptidase‐4 inhibitors: A real‐world target trial emulation in type 2 diabetes
von: Kathrine Kold Sørensen, et al.
Veröffentlicht: (2026)

Estimating the risk of cardiovascular outcomes and all‐cause mortality in individuals with type 2 diabetes: Validation of the UKPDS outcomes model using TECOS and EXSCEL data
von: Ruth L. Coleman, et al.
Veröffentlicht: (2025)

Association of cumulative exposure to cholesterol, high‐density lipoprotein, and glucose index with the risk of cardiovascular disease and all‐cause mortality: A longitudinal cohort study
von: Ruobing Tian, et al.
Veröffentlicht: (2025)

Association of semaglutide with less limb events in people with type 2 diabetes and peripheral artery disease or foot ulcers: An observational study comparing matched cohorts
von: Paola Caruso, et al.
Veröffentlicht: (2025)

Low serum 1,5‐anhydroglucitol is associated with increased risk of all‐cause and cardiovascular mortality in type 2 diabetes: A real‐world cohort study
von: Jiaying Ni, et al.
Veröffentlicht: (2025)

Biological aging mediates the associations of metabolic score for insulin resistance with all‐cause and cardiovascular disease mortality among US adults: A nationwide cohort study
von: Xiaoxuan Li, et al.
Veröffentlicht: (2024)

Sex‐specific associations between haemoglobin glycation index and the risk of cardiovascular and all‐cause mortality in individuals with pre‐diabetes and diabetes: A large prospective cohort study
von: Jingqi Yang, et al.
Veröffentlicht: (2024)

Diabetes and incident stroke and mediation by microvascular dysfunction: Pooled analysis of three population‐based studies
von: Indra L. M. Steens, et al.
Veröffentlicht: (2025)

Cost‐effectiveness of ON101 with general wound care for diabetic foot ulcers among patients with type 2 diabetes in Singapore: Analysis of a multi‐ethnic country in Asia
von: Hsuan‐Yu Su, et al.
Veröffentlicht: (2025)

Visit‐to‐visit HbA1c variability, risk of all‐cause mortality and diabetes‐related vascular complications among adult individuals with type 2 diabetes mellitus
von: Moses Yidong Lim, et al.
Veröffentlicht: (2026)

GLP ‐1 receptor agonists and cardiovascular events in metabolically healthy or unhealthy obesity
von: Tommaso Bucci, et al.
Veröffentlicht: (2025)

Long‐term all‐cause mortality of metabolic‐dysfunction associated steatotic liver disease based on body weight phenotypes following acute myocardial infarction: A retrospective cohort study
von: Jaycie Koh, et al.
Veröffentlicht: (2024)

Association of normal range of urinary albumin‐to‐creatinine ratio with all‐cause mortality among diabetic adults with preserved kidney function: National Health and Nutrition Examination Survey ( NHANES ) 2003–2018
von: Xiaoxia Pang, et al.
Veröffentlicht: (2025)

SGLT2 inhibitors are associated with a reduced incidence of atrial fibrillation in type 2 diabetes mellitus
von: Mark Luedde, et al.
Veröffentlicht: (2025)

Effects of GLP ‐1 receptor agonists on incidence and outcomes of ischemic stroke and myocardial infarction: A systematic review and meta‐analysis
von: Nawal Alammari, et al.
Veröffentlicht: (2025)

The global burden of early‐onset type 2 diabetes (1990–2050): An age–period–cohort analysis of incidence, disparities, and projections
von: Wanjun Yu, et al.
Veröffentlicht: (2025)

Does metformin reduce the risk of cancer in obesity and diabetes? A systematic review and meta‐analysis
von: Leonardo A. Mesquita, et al.
Veröffentlicht: (2024)

Risk acceleration by gout on major adverse cardiovascular events and all‐cause death in patients with diabetes and chronic kidney disease
von: Da Young Lee, et al.
Veröffentlicht: (2025)

Diabetes self‐management education and its association with hospital admissions and premature mortality: A scoping review and meta‐analysis
von: Gemma A. Lewis, et al.
Veröffentlicht: (2025)

Metabolomic risk predictors of diabetic foot complications: A longitudinal observational study in type 1 diabetes
von: Jonas A. Andersen, et al.
Veröffentlicht: (2025)

Diabetes mellitus and adverse clinical events in patients with atrial fibrillation: A report from the GLORIA ‐ AF registry phase III
von: Yang Liu, et al.
Veröffentlicht: (2024)

Normoalbuminuria—is it normal? The association of urinary albumin within the ‘normoalbuminuric’ range with adverse cardiovascular and mortality outcomes: A systematic review and meta‐analysis
von: Dvora R. Sehtman‐Shachar, et al.
Veröffentlicht: (2024)

Association between diabetes self‐management education attendance, hospital admissions and mortality in type 2 diabetes: A cohort analysis protocol
von: Gemma A. Lewis, et al.
Veröffentlicht: (2025)

Association of gestational diabetes with long‐term risk of premature mortality, and cardiovascular outcomes and risk factors: A retrospective cohort analysis in the UK Biobank
von: Moscho Michalopoulou, et al.
Veröffentlicht: (2024)

Glucagon‐like peptide‐1 receptor agonist treatment reduces body weight and improves glycaemic outcomes in patients with concurrent overweight/obesity and type 1 diabetes: A systematic review and meta‐analysis
von: Amanda R. Purcell, et al.
Veröffentlicht: (2025)